Suppr超能文献

头颈部鳞状细胞癌患者的血清可诱导处理细胞中微小RNA及靶基因表达谱的改变。

Blood Serum From Head and Neck Squamous Cell Carcinoma Patients Induces Altered MicroRNA and Target Gene Expression Profile in Treated Cells.

作者信息

Allen Brittany, Schneider Augusto, Victoria Berta, Nunez Lopez Yury O, Muller Mark, Szewczyk Mateusz, Pazdrowski Jakub, Majchrzak Ewa, Barczak Wojciech, Golusinski Wojciech, Golusinski Pawel, Masternak Michal M

机构信息

Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, United States.

Faculdade de Nutrição, Universidade Federal de Pelotas, Pelotas, Brazil.

出版信息

Front Oncol. 2018 Jun 11;8:217. doi: 10.3389/fonc.2018.00217. eCollection 2018.

Abstract

The head and neck squamous cell carcinoma (HNSCC) represents one of the most common cancers in humans. Close to 600,000 new diagnoses are made every year worldwide and over half of diagnosed patients will not survive. In view of this low survival rate, the development of novel cell-based assays for HNSCC will allow more mechanistic approaches for specific diagnostics for each individual patient. The cell-based assays will provide more informative data predicting cellular processes in treated patient, which in effect would improve patient follow up. More importantly, it will increase the specificity and effectiveness of therapeutic approaches. In this study, we investigated the role of serum from HNSCC patients on the regulation of microRNA (miRNA) expression in exposed cells . Next-generation sequencing of miRNA revealed that serum from HNSCC patients induced a different miRNA expression profile than the serum from healthy individuals. Out of 377 miRNA detected, we found that 16 miRNAs were differentially expressed when comparing cells exposed to serum from HNSCC or healthy individuals. The analysis of gene ontologies and pathway analysis revealed that these miRNA target genes were involved in biological cancer-related processes, including cell cycle and apoptosis. The real-time PCR analysis revealed that serum from HNSCC patients downregulate the expression level of five genes involved in carcinogenesis and two of these genes-P53 and SLC2A1-are direct targets of detected miRNAs. These novel findings provide new insight into how cancer-associated factors in circulation regulate the expression of genes and regulatory elements in distal cells in favor of tumorigenesis. This has the potential for new therapeutic approaches and more specific diagnostics with tumor-specific cell lines or single-cell assays for personalized treatment and early detection of primary tumors or metastasis.

摘要

头颈部鳞状细胞癌(HNSCC)是人类最常见的癌症之一。全球每年有近60万例新诊断病例,超过一半的确诊患者无法存活。鉴于这种低生存率,开发新的基于细胞的HNSCC检测方法将为每个患者的特定诊断提供更多的机制性方法。基于细胞的检测将提供更多信息丰富的数据,预测接受治疗患者的细胞过程,这实际上将改善患者的随访情况。更重要的是,它将提高治疗方法的特异性和有效性。在本研究中,我们调查了HNSCC患者血清对暴露细胞中微小RNA(miRNA)表达调控的作用。miRNA的下一代测序显示,HNSCC患者的血清诱导出与健康个体血清不同的miRNA表达谱。在检测到的377种miRNA中,我们发现,与暴露于HNSCC患者或健康个体血清的细胞相比,有16种miRNA表达存在差异。基因本体分析和通路分析表明,这些miRNA靶基因参与了与癌症相关的生物学过程,包括细胞周期和细胞凋亡。实时PCR分析显示,HNSCC患者的血清下调了五个参与致癌过程的基因的表达水平,其中两个基因——P53和SLC2A1——是检测到的miRNA的直接靶标。这些新发现为循环中的癌症相关因子如何调节远端细胞中的基因和调控元件表达以促进肿瘤发生提供了新的见解。这有可能为新的治疗方法以及使用肿瘤特异性细胞系或单细胞检测进行更特异性的诊断提供可能,以实现个性化治疗以及原发性肿瘤或转移的早期检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5620/6004400/3369055706cd/fonc-08-00217-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验